Clinical Trial Update: Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing insulin glargine (Lantus) with NPH insulin in adults with Type 2 diabetes who are insulin-naive and not adequately controlled on at le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED